Cost-effectiveness analysis of 23-valent pneumococcal polysaccharide vaccine for adults in China
{{output}}
Background: With population aging and the rising burden of chronic diseases, pneumococcal disease imposes increasing pressure on the healthcare system in China. This study evaluated the cost-effectiveness of the 23-valent pneumoc... ...
